Wedbush Cuts Price Target on Surface Oncology to $3 From $12, Citing New Clinical Data, Updated Pipeline Focus; Outperform Rating Kept
Wedbush Cuts Price Target on Surface Oncology to $3 From $12, Citing New Clinical Data, Updated Pipeline Focus; Outperform Rating Kept
Wedbush以新的临床数据和最新的管道焦点为由将表面肿瘤学的目标股价从12美元下调至3美元；维持跑赢大盘评级
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册